Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
70,086,593
-
Shares change
-
+1,950,561
-
Total reported value, excl. options
-
$303,466,627
-
Value change
-
+$3,780,454
-
Put/Call ratio
-
23%
-
Number of buys
-
41
-
Number of sells
-
33
-
Price
-
$4.33
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q1 2023
As of 31 Mar 2023 Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) had 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 70,086,593 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., M28 Capital Management LP, MAVERICK CAPITAL LTD, 683 Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Bellevue Group AG, PRIMECAP MANAGEMENT CO/CA/, Kynam Capital Management, LP, Artal Group S.A., and MILLENNIUM MANAGEMENT LLC.
This table shows 72 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.